Value of a secretomic approach for distinguishing patients with COVID‐19 viral pneumonia among patients with respiratory distress admitted to intensive care unit
Journal of Medical Virology · 2024-06 · 96 (6)
DOI: 10.1002/jmv.29756 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medical Virology, online erschienen am 20.06.2024. Verfasst von Angélique Blangy-Letheule und 17 weiteren Autor:innen. Beteiligte Einrichtung: Nantes Université, CHU Nantes, CNRS, INSERM, l'institut du thorax, Nantes, France. Hauptthemen laut MEDLINE: COVID-19, Intensive Care Units, Biomarkers. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Agence Nationale de la Recherche, Association sauve ton Cœur, Fondation d'entreprises Genavie.
Themen: Intensivpflege
Abstract (Originalsprache)
In intensive care units, COVID‐19 viral pneumonia patients (VPP) present symptoms similar to those of other patients with Nonviral infection (NV‐ICU). To better manage VPP, it is therefore interesting to better understand the molecular pathophysiology of viral pneumonia and to search for biomarkers that may clarify the diagnosis. The secretome being a set of proteins secreted by cells in response to stimuli represents an opportunity to discover new biomarkers. The objective of this study is to identify the secretomic signatures of VPP with those of NV‐ICU. Plasma samples and clinical data from NV‐ICU ( n = 104), VPP ( n = 30) or healthy donors (HD, n = 20) were collected at Nantes Hospital (France) upon admission. Samples were enriched for the low‐abundant proteins and analyzed using nontarget mass spectrometry. Specifically deregulated proteins (DEP) in VPP versus NV‐ICU were selected. Combinations of 2 to 4 DEPs were established. The differences in secretome profiles of the VPP and NV‐ICU groups were highlighted. Forty‐one DEPs were specifically identified in VPP compared to NV‐ICU. We describe five of the best combinations of 3 proteins (complement component C9, Ficolin‐3, Galectin‐3‐binding protein, Fibrinogen alpha, gamma and beta chain, Proteoglycan 4, Coagulation factor IX and Cdc42 effector protein 4) that show a characteristic receptor function curve with an area under the curve of 95.0%. This study identifies five combinations of candidate biomarkers in VPP compared to NV‐ICU that may help distinguish the underlying causal molecular alterations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Nantes Université, CHU Nantes, CNRS, INSERM, l'institut du thorax, Nantes, France.
- University of Paris-Est Créteil (UPEC), Inserm U955, Equipe 21, UMR_S955, APHP, Hôpital H. Mondor-A. Chenevier, Centre d'Investigation Clinique Biothérapie, Créteil, France.
- AP-HP, Hopital Henri Mondor, Creteil, France.
- Service d'Anesthésie-Réanimation et Médecine péri-Opératoire, Nouvel Hôpital Civil, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.
- Nantes Université, CHU Nantes, INSERM, Center for Research in Transplantation and Translational Immunology, Nantes, France.
- CHU Nantes, INSERM, Nantes Université, Anesthésie Réanimation, Nantes, France.
Förderung
- Agence Nationale de la Recherche
- Association sauve ton Cœur
- Fondation d'entreprises Genavie
- Société Française d'Anesthésie et de Réanimation
- Région Pays de la Loire
- European Union's Horizon 2020 research and innovation program
Zitieren
APA
Blangy-Letheule, A., Vergnaud, A., Dupas, T., Habert, D., Montnach, J., Oulehri, W., Hassoun, D., Denis, M., Lecomte, J., Persello, A., Roquilly, A., Courty, J., Seve, M., Leroux, A. A., Rozec, B., Bourgoin-Voillard, S., De Waard, M., & Lauzier, B. (2024). Value of a secretomic approach for distinguishing patients with COVID‐19 viral pneumonia among patients with respiratory distress admitted to intensive care unit. Journal of Medical Virology, 96(6). https://doi.org/10.1002/jmv.29756
Vancouver
Blangy-Letheule A, Vergnaud A, Dupas T, Habert D, Montnach J, Oulehri W, et al. Value of a secretomic approach for distinguishing patients with COVID‐19 viral pneumonia among patients with respiratory distress admitted to intensive care unit. Journal of Medical Virology. 2024;96(6). doi:10.1002/jmv.29756
BibTeX
@article{BlangyLetheule2024,
author = {Blangy-Letheule, Angélique and Vergnaud, Amandine and Dupas, Thomas and Habert, Damien and Montnach, Jérôme and Oulehri, Walid and Hassoun, Dorian and Denis, Manon and Lecomte, Jules and Persello, Antoine and Roquilly, Antoine and Courty, José and Seve, Michel and Leroux, Aurélia A and Rozec, Bertrand and Bourgoin-Voillard, Sandrine and De Waard, Michel and Lauzier, Benjamin},
title = {Value of a secretomic approach for distinguishing patients with COVID‐19 viral pneumonia among patients with respiratory distress admitted to intensive care unit},
journal = {Journal of Medical Virology},
year = {2024},
volume = {96},
number = {6},
doi = {10.1002/jmv.29756}
}
EUVIMED